#######################
# Document Properties #
#######################
SET DOCUMENT Copyright   = "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved."
SET DOCUMENT Licenses    = "CC BY 4.0"
SET DOCUMENT ContactInfo = "charles.hoyt@scai.fraunhofer.de"

SET DOCUMENT Name        = "The role of inflammasome in Alzheimer’s disease"
SET DOCUMENT Version     = "1.0.3"
SET DOCUMENT Description = ""
SET DOCUMENT Authors     = "Sandra Spalek"

###############
# Definitions #
###############

# Namespaces defined with regular expressions
# -------------------------------------------
DEFINE NAMESPACE DBSNP    AS PATTERN "rs[0-9]+"
DEFINE NAMESPACE TAXONOMY AS PATTERN "^\d+$"
DEFINE NAMESPACE PUBCHEM  AS PATTERN "^\d+$"

# Namespaces hosted on https://github.com/pharmacome/terminology
# --------------------------------------------------------------
DEFINE NAMESPACE MESH     AS URL "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/mesh-names.belns"
DEFINE NAMESPACE CHEBI    AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns"
DEFINE NAMESPACE DRUGBANK AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns"
DEFINE NAMESPACE ECCODE   AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns"
DEFINE NAMESPACE NCBIGENE AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns"
DEFINE NAMESPACE GFAM     AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc.genefamily-names.belns"
DEFINE NAMESPACE GO       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns"
DEFINE NAMESPACE HGNC     AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns"
DEFINE NAMESPACE MIRBASE  AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns"
DEFINE NAMESPACE HBP      AS URL "https://raw.githubusercontent.com/pharmacome/terminology/785431732a26d6809b4162d98b95687d16404e63/export/hbp.belns"

# Namespaces hosted on https://github.com/sorgerlab/famplex
# ---------------------------------------------------------
DEFINE NAMESPACE FPLX AS URL "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns"

# Namespaces hosted on https://arty.scai.fraunhofer.de/artifactory/bel
# --------------------------------------------------------------------
DEFINE NAMESPACE CTO      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns"
DEFINE NAMESPACE DO       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns"
DEFINE NAMESPACE HP       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns"
DEFINE NAMESPACE MGI      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mgi-mouse-genes/mgi-mouse-genes-20170725.belns"
DEFINE NAMESPACE RGD      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/rgd-rat-genes/rgd-rat-genes-20170725.belns"
DEFINE NAMESPACE INTERPRO AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/interpro/interpro-20170731.belns"

# Annotations hosted on https://arty.scai.fraunhofer.de/artifactory/bel/annotation
# --------------------------------------------------------------------------------
DEFINE ANNOTATION Anatomy       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno"
DEFINE ANNOTATION CellLine      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno"
DEFINE ANNOTATION CellStructure AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
DEFINE ANNOTATION Cell          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno"
DEFINE ANNOTATION Confidence    AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
DEFINE ANNOTATION Disease       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno"
DEFINE ANNOTATION MeSHAnatomy   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
DEFINE ANNOTATION MeSHDisease   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
DEFINE ANNOTATION Subgraph      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno"
DEFINE ANNOTATION TextLocation  AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"

##############
# Statements #
##############


SET STATEMENT_GROUP = "Sandra"

# Add statements below this comment

SET Citation = {"PubMed", "Ageing Res Rev. 2014 May;15:6-15. doi: 10.1016/j.arr.2013.12.007", "24561250"}

SET Evidence = "Inflammasomes involve in the maturation of IL-1β and IL-18 are expressed in neurons
(de Rivero Vaccari et al., 2008; Yang-Wei Fann et al., 2013; Zou and Crews, 2012)"
SET Confidence = "High"
SET Subgraph = "Interleukin signaling subgraph"
SET MeSHAnatomy = "Neurons"
complex(GO:"inflammasome complex") positiveCorrelation p(HGNC:IL1B)
complex(GO:"inflammasome complex") positiveCorrelation p(HGNC:IL18)

UNSET Subgraph
UNSET MeSHAnatomy

SET Evidence = "Trauma, a risk factor for AD, increases inflammasome expression in rat neurons (de Rivero Vaccari et
al., 2009; de Rivero Vaccari et al., 2008)"
SET Confidence = "Medium"
# SET Subgraph =
SET MeSHAnatomy = "Neurons"
path(MESH:"Trauma, Nervous System") -> path(MESH:"Alzheimer Disease")
path(MESH:"Trauma, Nervous System") -> complex(GO:"inflammasome complex")

UNSET MeSHAnatomy

SET Evidence = "Furthermore, postmortem brain tissues from stroke
patients show increase protein levels of inflammasomes in primary cortical neurons (Yang-
Wei Fann et al., 2013)"
SET Confidence = "High"
# SET Subgraph =
SET MeSHAnatomy = "Neurons"
path(MESH:Stroke) -> complex(GO:"inflammasome complex")

UNSET MeSHAnatomy

SET Evidence = "Interleukins, in particular IL-1β
and IL-18, are upregulated in AD brain, and the overexpression of IL-1β or IL-18 is critical
for the onset of the inflammatory process (Rubio-Perez and Morillas-Ruiz, 2012), and both
mediate the expression of a vast array of inflammatory genes (Weber et al., 2010)"
SET Confidence = "High"
SET Subgraph = {"Interleukin signaling subgraph","Inflammatory response subgraph"}
path(MESH:"Alzheimer Disease") positiveCorrelation p(HGNC:IL1B)
path(MESH:"Alzheimer Disease") positiveCorrelation p(HGNC:IL18)
p(HGNC:IL1B) -> bp(GO:"inflammatory response")
p(HGNC:IL18) -> bp(GO:"inflammatory response")

SET Evidence = "IL-1β and IL-18 are synthesized as inactive precursors, proIL-1β and proIL-18, respectively, and
require inflammasomes for their maturation"
SET Confidence = "High"
SET Subgraph = "Interleukin signaling subgraph"
complex(GO:"inflammasome complex") -> p(HGNC:IL1B)
complex(GO:"inflammasome complex") -> p(HGNC:IL18)

SET Evidence = "The basic components of inflammasomes include a NOD-like receptor (NLR)
that recognizes danger signals or ligands, and procaspase-1 which is central to inflammasome activation"
SET Confidence = "Medium"
SET Subgraph = "Caspase subgraph"
complex(GO:"inflammasome complex") hasComponents list(a(MESH:"NLR Proteins"),p(HGNC:CASP1))

SET Evidence = "They include the adaptor
protein, ASC (apoptosis-associated speck-like protein containing a caspase recruitment
domain), which is an essential component of the NLRP1, NLRP2 and NLRP3
inflammasomes, but not of the more complex NLRC4 inflammasome (Martinon et al., 2009;
Minkiewicz et al., 2013; Schroder and Tschopp, 2010)"
SET Confidence = "Medium"
SET Subgraph = "Caspase subgraph"
complex(GO:"NLRP1 inflammasome complex") hasComponent p(HGNC:PYCARD)
p(HGNC:PYCARD) -- composite(p(HGNC:NLRP2),complex(GO:"inflammasome complex"))
complex(GO:"NLRP3 inflammasome complex") hasComponent p(HGNC:PYCARD)

SET Evidence = "Under certain but not all conditions
ASC (Martinon et al., 2009) or Naip5 (NLR family, apoptosis inhibitory protein 5)
(Lightfield et al., 2011) is required for the activity of the NLRC4 inflammasome"
# NLRC4 inflammasome = IPAF inflammasome complex"
SET Confidence = "High"
SET Subgraph = "Caspase subgraph"
p(HGNC:PYCARD) -> act(complex(GO:"IPAF inflammasome complex"))
p(HGNC:NAIP) -> act(complex(GO:"IPAF inflammasome complex"))

UNSET Subgraph

SET Evidence = "They are structurally characterized by three distinct domains: a domain of leucine rich repeats (LRRs)
for ligand sensing, a NACHT domain (also called nucleotide-binding oligomerization
domain (NOD)) that facilitates oligomerization, and an effector domain which consists of
one of three domains, i.e. a pyrin (PYD), CARD (caspase activation and recruitment
domains), or BIR (baculovirus IAP repeat) domain (Martinon et al., 2009)"
SET Confidence = "High"
# they = NOD-like receptor protein
# Pyrin domain = DAPIN domain
# SET Subgraph =
p(INTERPRO:"Leucine-rich repeat-containing adjacent domain") partOf a(MESH:"NLR Proteins")
p(INTERPRO:"NACHT-associated domain") partOf a(MESH:"NLR Proteins")
p(INTERPRO:"DAPIN domain") partOf p(INTERPRO:"NACHT-associated domain")
p(INTERPRO:"CARD domain") partOf p(INTERPRO:"NACHT-associated domain")
p(INTERPRO:"BIR repeat") partOf p(INTERPRO:"NACHT-associated domain")

SET Evidence = "In response to danger signals, inflammasomes assemble by self-oligomerizing the NLRs through
interactions with the NACHT domain (van de Veerdonk et al., 2011)"
SET Confidence = "High"
# Alarmins = Damage-Associated Molecular Pattern Molecules (DAMPs)
# SET Subgraph =
a(MESH:"Pathogen-Associated Molecular Pattern Molecules") -> complex(GO:"inflammasome complex")
a(MESH:Alarmins) -> complex(GO:"inflammasome complex")
complex(a(MESH:"NLR Proteins"),p(INTERPRO:"NACHT-associated domain")) -> complex(GO:"inflammasome complex")

SET Evidence = "As for the NLRP1 and NLRP3 inflammasomes, the oligomerzied NLRs recruit and
interact with the adaptor protein ASC, which in turn recruits the effector protein
procaspase-1 that is central to the activation of inflammasomes (Huang et al., 2013)"
SET Confidence = "High"
SET Subgraph = "Caspase subgraph"
complex(p(HGNC:PYCARD),p(HGNC:NLRP1),p(HGNC:CASP1)) -> act(complex(GO:"NLRP1 inflammasome complex"))
complex(p(HGNC:PYCARD),p(HGNC:NLRP3),p(HGNC:CASP1)) -> act(complex(GO:"NLRP3 inflammasome complex"))

SET Evidence = "Caspase-1 is the protease that
cleaves the precursor of the proinflammatory molecules to form their mature form, such as
IL-1β and IL-18 (Schroder and Tschopp, 2010)"
SET Confidence = "High"
SET Subgraph = {"Caspase subgraph","Interleukin signaling subgraph"}
p(HGNC:CASP1) -> p(HGNC:IL1B)
p(HGNC:CASP1) -> p(HGNC:IL18)

UNSET Subgraph

SET Evidence = "The activators of the inflammasomes can be
divided into two categories; pathogen associated molecular patterns (PAMPs) activate a
host-defense reaction, and damage associated molecular patterns (DAMPs) activate a self-defense
mechanism in response to danger signals (Salminen et al., 2008)"
SET Confidence = "High"
# SET Subgraph =
a(MESH:"Pathogen-Associated Molecular Pattern Molecules") -> act(complex(GO:"inflammasome complex"))
a(MESH:Alarmins) -> act(complex(GO:"inflammasome complex"))

SET Evidence = "Activators include bacteria, virus, fungus, protoza, microbial proteins, crystalline urea, RNA, Alum, ATP,
potassium efflux, fatty acids, Aβ, and most recently, degraded mitochondrial DNA (Liu et
al., 2013a; Mathew et al., 2012; Schmidt and Lenz, 2012)"
SET Confidence = "High"
# SET Subgraph =
a(MESH:Bacteria) -> act(complex(GO:"inflammasome complex"))
a(MESH:Viruses) -> act(complex(GO:"inflammasome complex"))
a(MESH:Fungi) -> act(complex(GO:"inflammasome complex"))
a(MESH:RNA) -> act(complex(GO:"inflammasome complex"))
a(CHEBI:"potassium aluminium sulfate") -> act(complex(GO:"inflammasome complex"))
a(CHEBI:ATP) -> act(complex(GO:"inflammasome complex"))
a(CHEBI:"potassium(1+)") -> act(complex(GO:"inflammasome complex"))
a(CHEBI:"fatty acid") -> act(complex(GO:"inflammasome complex"))
deg(a(MESH:"DNA, Mitochondrial")) -> act(complex(GO:"inflammasome complex"))

SET Subgraph = "Amyloidogenic subgraph"
a(CHEBI:"amyloid-beta") -> act(complex(GO:"inflammasome complex"))

SET Evidence = "In the CNS, the production of IL-1β by inflammasomes, specifically NLRP1, NLRP2, NLRP3 and NLRC4,
is well-characterized as compared to other interleukins (Minkiewicz et al., 2013; Trendelenburg, 2008)"
SET Confidence = "High"
SET Subgraph = "Interleukin signaling subgraph"
SET MeSHAnatomy = "Central Nervous System"
complex(GO:"NLRP1 inflammasome complex") -> p(HGNC:IL1B)
composite(p(HGNC:NLRP2),complex(GO:"inflammasome complex")) -> p(HGNC:IL1B)
complex(GO:"NLRP3 inflammasome complex") -> p(HGNC:IL1B)
complex(GO:"IPAF inflammasome complex") -> p(HGNC:IL1B)

UNSET MeSHAnatomy

SET Evidence = "Spinal cord injury can activate the NLRP1
inflammasome to produce IL-1β in rat spinal cord neurons (de Rivero Vaccari et al., 2008)"
SET Confidence = "High"
SET Subgraph = "Interleukin signaling subgraph"
SET MeSHAnatomy = "Neurons"
path(MESH:"Spinal Cord Injuries") -> act(complex(GO:"NLRP1 inflammasome complex"))
act(complex(GO:"NLRP1 inflammasome complex")) -> p(HGNC:IL1B)

UNSET Subgraph
UNSET MeSHAnatomy

SET Evidence = "A subsequent study demonstrated that P2X7 purinergic receptor is involved in the activation
of NLRP1 inflammasome (Silverman et al., 2009)"
SET Confidence = "High"
# SET Subgraph =
p(HGNC:P2RX7) -> act(complex(GO:"NLRP1 inflammasome complex"))

SET Evidence = "Given that P2X4 and P2X7 are the major
purinergic P2X receptor subtypes, a study of spinal cord injury in P2X4 knock-out mice
showed a significant reduction in inflammasome activation and proinflammatory cytokine
production as compared to wild type (de Rivero Vaccari et al., 2012), supporting the
involvement of purinergic receptor P2X4 in the activation of the NLRP1 inflammasome"
SET Confidence = "High"
# SET Subgraph =
p(MGI:P2rx4) -> act(complex(GO:"NLRP1 inflammasome complex"))
p(MGI:P2rx7) -> act(complex(GO:"NLRP1 inflammasome complex"))

SET Evidence = "Similarly, the P2X7 purinergic receptor has been shown to activate the NLRP1
inflammasome in primary neurons (Silverman et al., 2009)"
SET Confidence = "High"
# SET Subgraph =
p(HGNC:P2RX7) -> act(complex(GO:"NLRP1 inflammasome complex"))

SET Evidence = "ATP, a danger-associated molecular pattern that is released from damaged cells after brain
injury, activates the NLRP2 inflammasome, which consists of the NLRP2 receptor, ASC
and caspase-1, in human astrocytes (Minkiewicz et al., 2013)"
SET Confidence = "High"
SET Subgraph = "Caspase subgraph"
a(CHEBI:ATP) -> composite(p(HGNC:NLRP2),complex(GO:"inflammasome complex"))
composite(p(HGNC:NLRP2),complex(GO:"inflammasome complex")) -- p(HGNC:CASP1)
composite(p(HGNC:NLRP2),complex(GO:"inflammasome complex")) -- p(HGNC:NLRP2)
composite(p(HGNC:NLRP2),complex(GO:"inflammasome complex")) -- p(HGNC:PYCARD)

SET Evidence = "The ATP-induced activation
of the NLRP2 inflammasome interacts with the ATP-release pannexin 1 channel and ATP-gated
P2X7 receptor leading to the maturation of IL-1β (Minkiewicz et al., 2013)"
SET Confidence = "High"
SET Subgraph = "Interleukin signaling subgraph"
a(CHEBI:ATP) -> composite(p(HGNC:NLRP2),complex(GO:"inflammasome complex"))
composite(p(HGNC:NLRP2),complex(GO:"inflammasome complex"),p(HGNC:PANX1),p(HGNC:P2RX7)) -> p(HGNC:IL1B)

SET Evidence = "In vivo and cell studies demonstrate that fibrillar Aβ activates the NLRP3 inflammasome
which is composed of the NLRP3 receptor, ASC and caspase-1, to produce IL-1β in
microglia (Halle et al., 2008)"
SET Confidence = "Medium"
SET Subgraph = "Amyloidogenic subgraph"
SET Cell = "microglial cell"
a(HBP:HBP00038) -> act(complex(GO:"NLRP3 inflammasome complex"))
complex(GO:"NLRP3 inflammasome complex") hasComponents list(p(HGNC:NLRP3), p(HGNC:PYCARD), p(HGNC:CASP1))
complex(GO:"NLRP3 inflammasome complex") -> p(HGNC:IL1B)

UNSET Cell

SET Evidence = "Phagocytosis and subsequent lysosomal damage trigger by Aβ
initiate the activation of the NLRP3 inflammasome in the microglia (Halle et al., 2008)"
SET Confidence = "High"
SET Subgraph = "Amyloidogenic subgraph"
SET Cell = "microglial cell"
a(CHEBI:"amyloid-beta") -> bp(GO:phagocytosis)
bp(GO:phagocytosis) -> act(complex(GO:"NLRP3 inflammasome complex"))

SET Subgraph = {"Amyloidogenic subgraph","Endosomal lysosomal subgraph"}
a(CHEBI:"amyloid-beta") -| a(GO:lysosome)
a(GO:lysosome) -| act(complex(GO:"NLRP3 inflammasome complex"))

UNSET Subgraph
UNSET Cell

SET Evidence = "In support, a recent study in APP/PS1 mice confirms that the NLRP3 inflammasome
contributes to the AD pathology (Heneka et al., 2013)"
SET Confidence = "Medium"
# SET Subgraph =
complex(GO:"NLRP3 inflammasome complex") -- path(MESH:"Alzheimer Disease")

SET Evidence = "Deficiency of the NLRP3 gene
reduces Aβ deposition and plays a protective role on memory and behavior (Heneka et al.,2013)"
SET Confidence = "High"
SET Subgraph = {"Amyloidogenic subgraph","Caspase subgraph"}
g(HGNC:NLRP3) -> a(CHEBI:"amyloid-beta")
g(HGNC:NLRP3) -| bp(GO:memory)
g(HGNC:NLRP3) -| bp(GO:behavior)

SET Evidence = "Similarly, inhibiting the NLRP3 inflammasome reduces the neuritic plaque burden in
an AD transgenic mouse model (Shi et al., 2013)"
SET Confidence = "High"
SET Subgraph = "Amyloidogenic subgraph"
SET MeSHDisease = "Alzheimer Disease"
SET MeSHAnatomy = "Neurons"
complex(GO:"NLRP3 inflammasome complex") -> path(MESH:"Plaque, Amyloid")

UNSET MeSHDisease
UNSET MeSHAnatomy

SET Evidence = "Palmitate, a fatty acid, activates the NLRC4 inflammasome in primary astrocytes leading to
the release of IL-1β (Liu and Chan, 2014)"
SET Confidence = "High"
SET Subgraph = "Interleukin signaling subgraph"
SET Cell = "astrocyte"
a(CHEBI:hexadecanoate) -> complex(GO:"IPAF inflammasome complex")
complex(GO:"IPAF inflammasome complex") -> sec(p(HGNC:IL1B))

UNSET Cell

SET Evidence = "The adaptor protein ASC is important for the
activation of NLRC4 inflammasome in astrocytes, while Naip 5 is not (Liu and Chan, 2014)"
SET Confidence = "High"
SET Subgraph = "Caspase subgraph"
SET Cell = "astrocyte"
p(HGNC:PYCARD) -> act(complex(GO:"IPAF inflammasome complex"))

UNSET Cell

SET Evidence = "Like IL-1β, in most cases, the mature secretable form
of IL-18 is generated by caspase-1 through the activation of inflammasome"
SET Confidence = "High"
SET Subgraph = {"Caspase subgraph","Interleukin signaling subgraph"}
p(HGNC:CASP1) -> p(HGNC:IL18)
act(complex(GO:"inflammasome complex")) -> act(p(HGNC:CASP1))

SET Subgraph = "Interleukin signaling subgraph"
act(complex(GO:"inflammasome complex")) -> p(HGNC:IL18)

SET Evidence = "However the maturation of IL-18 and IL-1β could be regulated by the same type of inflammasome"
SET Confidence = "High"
SET Subgraph = "Interleukin signaling subgraph"
complex(GO:"inflammasome complex") reg p(HGNC:IL18)
complex(GO:"inflammasome complex") reg p(HGNC:IL1B)

SET Evidence = "For example, down-regulation of NLRP1 in macrophages trigger by Cordyceps sinensis
mycelium reduces both IL-18 and IL-1β levels (Huang et al., 2013)"
SET Confidence = "High"
SET Subgraph = "Interleukin signaling subgraph"
SET Cell = "macrophage"
p(HGNC:NLRP1) -> p(HGNC:IL18)
p(HGNC:NLRP1) -> p(HGNC:IL1B)

UNSET Cell

SET Evidence = "A recent report shows that IL-18 and IL-1β
are secreted from primed murine dendritic cells in response to Listeria protein p60, but
inhibiting NLRP3 reduces the production of IL-1β, but not IL-18 secretion (Schmidt and
Lenz, 2012)"
SET Confidence = "Low"
SET MeSHAnatomy = "Dendritic Cells"
SET Subgraph = "Interleukin signaling subgraph"
# uniprot:Probable endopeptidase p60 (P21171) -> sec(p(MGI:Il1b))
# uniprot:Probable endopeptidase p60 (P21171) -> sec(p(MGI:Il18))

SET Confidence = "High"
SET Subgraph = {"Caspase subgraph","Interleukin signaling subgraph"}
p(MGI:Nlrp3) -> p(MGI:Il1b)

SET Evidence = "Spinal cord injury causes IL-18 and IL-1β release from neuronal cells through the activation
of the NLRP1 inflammasome, composed of receptor NLRP1, adaptor protein ASC,
caspase-1, caspase-11 and X-linked inhibitor of apoptosis protein (de Rivero Vaccari et al.,
2008)"
SET Confidence = "High"
SET Subgraph = "Interleukin signaling subgraph"
SET MeSHAnatomy = "Neurons"
path(MESH:"Spinal Cord Injuries") -> act(complex(GO:"NLRP1 inflammasome complex"))
path(MESH:"Spinal Cord Injuries") -> sec(p(HGNC:IL18))
path(MESH:"Spinal Cord Injuries") -> sec(p(HGNC:IL1B))
act(complex(GO:"NLRP1 inflammasome complex")) -> sec(p(HGNC:IL18))
act(complex(GO:"NLRP1 inflammasome complex")) -> sec(p(HGNC:IL1B))

UNSET MeSHAnatomy
SET Confidence = "Medium"
SET Subgraph = "Caspase subgraph"
complex(GO:"NLRP1 inflammasome complex") hasComponents list(p(HGNC:NLRP1),p(HGNC:PYCARD),p(HGNC:CASP1),p(HGNC:CASP4))

SET Subgraph = "XIAP subgraph"
complex(GO:"NLRP1 inflammasome complex") hasComponent p(HGNC:XIAP)


SET Evidence = "ASC neutralization reduces the upregulation in IL-18 and IL-1β levels (de Rivero
Vaccari et al., 2008)"
SET Confidence = "High"
SET Subgraph = {"Caspase subgraph","Interleukin signaling subgraph"}
p(HGNC:PYCARD) -> p(HGNC:IL18)
p(HGNC:PYCARD) -> p(HGNC:IL1B)

UNSET Subgraph

SET Evidence = "Spinal cord injury elevates extracellular ATP levels during
neuroinflammation, which may act on purinergic receptors to trigger the activation of
inflammasome (de Rivero Vaccari et al., 2012; Minkiewicz et al., 2013)"
# SET Subgraph =
SET Confidence = "Medium"
SET MeSHAnatomy = "Extracellular Space"
path(MESH:"Spinal Cord Injuries") -> a(CHEBI:ATP)
UNSET MeSHAnatomy
a(CHEBI:ATP) -> act(complex(GO:"inflammasome complex"))

SET Evidence = "However, upon further study of purinergic receptor P2X4 knockout mice with spinal cord injury, the
production of IL-1β but not of IL-18 reduces in the neurons as compared with wild-type
mice (de Rivero Vaccari et al., 2012)"
SET Confidence = "High"
SET Subgraph = "Interleukin signaling subgraph"
SET MeSHDisease = "Spinal Cord Injuries"
SET MeSHAnatomy = "Neurons"
p(MGI:P2rx4) -> p(HGNC:IL1B)

UNSET MeSHDisease
UNSET MeSHAnatomy

SET Evidence = "In human astrocytes, ATP released from damaged or dying cells after traumatic brain injury
activates the NLRP2 inflammasome, leading to the maturation of both IL-1β and IL-18
(Minkiewicz et al., 2013)"
SET Confidence = "Medium"
SET Subgraph = "Interleukin signaling subgraph"
SET Cell = "astrocyte"
path(MESH:"Brain Injuries, Traumatic") -> bp(GO:"cell death")
bp(GO:"cell death") -> sec(a(CHEBI:ATP))
a(CHEBI:ATP) -> composite(p(HGNC:NLRP2),complex(GO:"inflammasome complex"))
composite(p(HGNC:NLRP2),complex(GO:"inflammasome complex")) -> p(HGNC:IL1B)
composite(p(HGNC:NLRP2),complex(GO:"inflammasome complex")) -> p(HGNC:IL18)

UNSET Cell

SET Evidence = "Aging, another risk factor of AD, has been found to activate the NLRP1 inflammasome and
upregulate IL-18 and IL-1β levels in the hippocampus of aged mice (Mawhinney et al.,
2011)"
SET Confidence = "Medium"
SET Subgraph = "Interleukin signaling subgraph"
SET MeSHAnatomy = "Hippocampus"
bp(GO:aging) positiveCorrelation path(MESH:"Alzheimer Disease")
bp(GO:aging) -> act(complex(GO:"NLRP1 inflammasome complex"))
bp(GO:aging) -> p(HGNC:IL1B)
bp(GO:aging) -> p(HGNC:IL18)

UNSET MeSHAnatomy

SET Evidence = "Recently we identify that palmitate activates the NLRC4 inflammasome in
primary astrocytes to release IL-1β, and ASC participates in the activation of the NLRC4 inflammasome (Liu and Chan, 2014)"
SET Confidence = "Medium"
SET Subgraph = "Interleukin signaling subgraph"
SET Cell = "astrocyte"
a(CHEBI:hexadecanoate) -> act(complex(GO:"IPAF inflammasome complex"))
act(complex(GO:"IPAF inflammasome complex")) -> sec(p(HGNC:IL1B))

SET Subgraph = "Caspase subgraph"
p(HGNC:PYCARD) -> act(complex(GO:"IPAF inflammasome complex"))

UNSET Cell

SET Evidence = "Reducing NLRC4 or ASC levels in the palmitate (PA)-treated astrocytes significantly
reduces IL-1β production (Liu and Chan, 2014)"
SET Confidence = "High"
SET Subgraph = {"Caspase subgraph","Interleukin signaling subgraph"}
SET Cell = "astrocyte"
composite(a(CHEBI:hexadecanoate),p(HGNC:PYCARD)) -> p(HGNC:IL1B)
composite(a(CHEBI:hexadecanoate),p(HGNC:NLRC4)) -> p(HGNC:IL1B)

UNSET Cell

SET Evidence = "In addition, NLRC4 and ASC levels are
upregulated in the brains of AD patients (Liu and Chan, 2014), suggesting a possible role of
the NLRC4 inflammasome in AD pathogenesis"
SET Confidence = "Medium"
SET Subgraph = "Caspase subgraph"
path(MESH:"Alzheimer Disease") positiveCorrelation p(HGNC:PYCARD)
path(MESH:"Alzheimer Disease") positiveCorrelation p(HGNC:NLRC4)
complex(GO:"IPAF inflammasome complex") -- path(MESH:"Alzheimer Disease")

SET Evidence = "These studies highlighted the role of saturated fatty acids in the production of IL-1β by
inflammasomes, i.e. NLRC4"
SET Confidence = "High"
SET Subgraph = "Interleukin signaling subgraph"
a(CHEBI:"saturated fatty acid") -> p(HGNC:IL1B)
complex(GO:"IPAF inflammasome complex") -> p(HGNC:IL1B)

UNSET Subgraph

SET Evidence = "Probenecid, an inhibitor of
pannexin 1, has been shown to significantly inhibit the expression and activation of the
NLRP2 inflammasome, and the maturation of bothIL-1β and IL-18 in human astrocytes
induced by ATP (Minkiewicz et al., 2013)"
SET Confidence = "Medium"
SET Cell = "astrocyte"
# SET Subgraph =
a(CHEBI:probenecid) -| p(HGNC:PANX1)
a(CHEBI:probenecid) -| composite(p(HGNC:NLRP2),complex(GO:"inflammasome complex"))
p(HGNC:PANX1) -> composite(p(HGNC:NLRP2),complex(GO:"inflammasome complex"))

SET Subgraph = "Interleukin signaling subgraph"
a(CHEBI:probenecid) -| p(HGNC:IL1B)
a(CHEBI:probenecid) -| p(HGNC:IL18)
p(HGNC:PANX1) -> p(HGNC:IL1B)
p(HGNC:PANX1) -> p(HGNC:IL18)

UNSET Subgraph
UNSET Cell

SET Evidence = "Probenecid has also been demonstrated to reduce
the activation of the NLRP1 inflammasome, and improve the learning performance in age-related
cognitive decline (Mawhinney et al., 2011)"
SET Confidence = "High"
# SET Subgraph =
a(CHEBI:probenecid) -| act(complex(GO:"NLRP1 inflammasome complex"))
a(CHEBI:probenecid) -> bp(GO:learning)

SET Evidence = "In addition, Brilliant Blue G (BBG), a
P2X7 receptor antagonist, inhibits ATP-induced activation of the NLRP2 inflammasome in
human astrocytes (Minkiewicz et al., 2013)"
SET Confidence = "Medium"
# SET Subgraph =
SET Cell = "astrocyte"
a(PUBCHEM:6324599) -| act(p(HGNC:P2RX7))
a(CHEBI:ATP) -> composite(p(HGNC:NLRP2),complex(GO:"inflammasome complex"))
a(PUBCHEM:6324599) -| composite(p(HGNC:NLRP2),complex(GO:"inflammasome complex"))

UNSET Cell

SET Evidence = "P2X4 knock-out mice has been shown to
decrease the level of IL-1β and to have impair inflammasome signaling (de Rivero Vaccari
et al., 2012)"
SET Confidence = "High"
SET Subgraph = "Interleukin signaling subgraph"
p(MGI:P2rx4) -> p(HGNC:IL1B)
p(MGI:P2rx4) -> act(complex(GO:"inflammasome complex"))

SET Evidence = "In support, knockout of NLRP3 and caspase-1 have
been shown to suppress amyloidogenesis and neuropathology, and improve cognition in AD
transgenic mice (Heneka et al., 2013)"
SET Confidence = "High"
SET MeSHDisease = "Alzheimer Disease"
SET Subgraph = {"Amyloidogenic subgraph","Caspase subgraph"}
p(MGI:Nlrp3) -> bp(GO:"amyloid-beta formation")
p(MGI:Casp1) -> bp(GO:"amyloid-beta formation")

SET Subgraph = "Caspase subgraph"
p(MGI:Nlrp3) -> a(MESH:Neuropathology)
p(MGI:Casp1) -> a(MESH:Neuropathology)
p(MGI:Nlrp3) -| bp(GO:cognition)
p(MGI:Casp1) -| bp(GO:cognition)

UNSET Subgraph
UNSET MeSHDisease
UNSET Confidence
